Search

Your search keyword '"Mahmoud Barbir"' showing total 77 results

Search Constraints

Start Over You searched for: Author "Mahmoud Barbir" Remove constraint Author: "Mahmoud Barbir"
77 results on '"Mahmoud Barbir"'

Search Results

1. Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)

2. Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis

Catalog

Books, media, physical & digital resources

3. Obesity and COVID-19: What are the Consequences?

4. Diabetes and COVID-19: Short- and Long-Term Consequences

5. Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis

6. Evaluation of a novel rapid genomic test including polygenic risk scores for the diagnosis and management of familial hypercholesterolaemia

7. Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trial

8. Diagnosis and management of children and young people with familial hypercholesterolaemia

9. Diagnosis, management and prognosis of familial hypercholesterolaemia in a UK tertiary cardiac centre

10. Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)

11. Prevalence of cardiovascular events in genetically confirmed versus unconfirmed familial hypercholesterolaemia

12. Prevalence of obstructive coronary artery disease and prognosis in patients with stable symptoms and a zero-coronary calcium score

13. Lipoprotein apheresis in pregnancy

14. Lipoprotein(a): the underutilized risk factor for cardiovascular disease

15. Correction: Lipid Profiles in Lyme Borreliosis: A Potential Role for Apheresis?

16. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017

17. Lipid Profiles in Lyme Borreliosis: A Potential Role for Apheresis?

20. Corrigendum to 'Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017' [Atherosclerosis 290 (November 2019) 44–51]

21. P6273Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a)

22. 68 A multi-disciplinary approach to delivering PCSK9 inhibitor therapy – first 12 months experience at a specialist cardiothoracic centre

23. The impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a): Objectives and methods of a randomised controlled trial

24. Vascular access in lipoprotein apheresis: a retrospective analysis from the UK's largest lipoprotein apheresis centre

25. Oxidised LDL and Anti-oxidised LDL antibodies are reduced by lipoprotein apheresis in a randomised controlled trial on patients with refractory angina and elevated lipoprotein(A)

26. Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial

27. Cardiac Rehabilitation to Improve Physical Functioning in Refractory Angina: A Pilot Study

30. Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe

31. Autogenic training to manage symptomology in women with chest pain and normal coronary arteries

32. Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries

33. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre

34. High prevalence of raised lipoprotein(a) in patients with refractory angina

35. Role of computed tomography in risk assessment for coronary heart disease

36. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation

39. Low-density lipoprotein apheresis is effective in reducing lipoprotein(a) levels and in improving symptoms in a patient with refractory angina secondary to accelerated coronary artery disease

40. Effects of cerivastatin on vascular function of human radial and left internal thoracic arteries

41. 94 Oxidised ldl levels correlate with lipoprotein(a) levels and are reduced by lipoprotein apheresis in a randomised study on patients with refractory angina and raised lipoprotein?(a)

42. CHANGES IN THROMBOTIC PARAMETERS IN PATIENTS WITH REFRACTORY ANGINA AND RAISED LIPOPROTEIN(A) TREATED WITH LIPOPROTEIN APHERESIS

43. Incidence and clinical relevance of coronary calcification detected by electron beam computed tomography in heart transplant recipients

44. Is there a place for LDL-apheresis in the management of raised cholesterol?

45. Coronary calcification detected by ultrafast computed tomography is a predictor of cardiac events in heart transplant recipients

46. 4 years' cascade genetic testing for familial hypercholesterolaemia in England – Increased referrals and ascertainment

48. Ultrafast computed tomographic scanning for detection of coronary disease in cardiac transplant recipients

49. Translational lessons from a case of combined heart and liver transplantation for familial hypercholesterolemia 20 years post-operatively

50. Early and long term results of re-operation for coronary artery disease